BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/26/2023 6:08:50 AM | Browse: 115 | Download: 301
 |
Received |
|
2022-11-18 06:34 |
|
Peer-Review Started |
|
2022-11-18 06:36 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-02-17 08:17 |
|
Revised |
|
2023-03-03 05:18 |
|
Second Decision |
|
2023-03-30 03:31 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-03-30 09:00 |
|
Articles in Press |
|
2023-03-30 09:00 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-04-20 13:49 |
|
Publish the Manuscript Online |
|
2023-04-26 06:08 |
| ISSN |
1949-8470 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Radiomic advances in the transarterial chemoembolization related therapy for hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tian-You Chen, Zong-Guo Yang, Ying Li and Mao-Quan Li |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mao-Quan Li, MD, PhD, Director, Professor, Department of Interventional & Vascular Surgery, Tenth People's Hospital of Tongji University, China; Institute of Interventional & Vascular Surgery, Tongji University, No. 301 Middle Yan Chang Road, Shanghai 200433, China. cjr.limaoquan@vip.163.com |
| Key Words |
Transarterial chemoembolization; Hepatocellular carcinoma; Radiomics; Magnetic resonance imaging; Computed tomography |
| Core Tip |
Hepatic cancer is a highly varied primary liver malignancy, and distinct tumor stage necessitate different techniques to guarantee appropriate therapeutic efficacy. Radiomics is a potential method, which can predict the benefits of patients with different treatment methods and different tumor stages through the obtained the potential information of clinical medical imaging that is difficult to identify with the naked eye, and predict the outcome of patients, thereby assisting precision medical decision-making. In this paper, we propose and discuss the possible use of radiomics in the selection of treatment modalities and efficacy prediction for liver cancer. |
| Publish Date |
2023-04-26 06:08 |
| Citation |
Chen TY, Yang ZG, Li Y, Li MQ. Radiomic advances in the transarterial chemoembolization related therapy for hepatocellular carcinoma. World J Radiol 2023; 15(4): 89-97 |
| URL |
https://www.wjgnet.com/1949-8470/full/v15/i4/89.htm |
| DOI |
https://dx.doi.org/10.4329/wjr.v15.i4.89 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
